P&G Hygiene and Health Care Intrinsic Value
P&G Hygiene and Health Care (PGHH) median intrinsic value is ₹3835.15 from 10 valuation models (range ₹1497–₹8500), vs current price ₹7486.00 — -48.8% downside (Trading Above Calculated Value), margin of safety -95.2%. See P&G Hygiene and Health Care P/B ratio trends to compare market price against book value per share.
PGHH Valuation Methods Summary — DCF, Graham Number & P/E
P&G Hygiene and Health Care intrinsic value across 10 models vs current price ₹7486.00 — upside/downside and value range per method. For current market price and key ratios, visit P&G Hygiene and Health Care screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹6090.00 | ₹4872.00 - ₹7308.00 | -18.6% | EPS: ₹243.60, Sector P/E: 25x |
| Book Value Method | asset | ₹1497.20 | ₹1347.48 - ₹1646.92 | -80.0% | Book Value/Share: ₹228.48, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2245.80 | ₹2021.22 - ₹2470.38 | -70.0% | Revenue/Share: ₹1299.70, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹4069.09 | ₹3662.18 - ₹4476.00 | -45.6% | EBITDA: ₹1119.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹3489.11 | ₹2791.29 - ₹4186.93 | -53.4% | CF Growth: 12.7%, Discount: 15% |
| PEG Ratio Method | growth | ₹2245.80 | ₹2021.22 - ₹2470.38 | -70.0% | EPS Growth: 3.9%, Fair P/E: 3.1x |
| Growth Adjusted P/E | growth | ₹4429.12 | ₹3986.21 - ₹4872.03 | -40.8% | Revenue Growth: 2.0%, Adj P/E: 18.2x |
| ROE Based Valuation | profitability | ₹3835.15 | ₹3451.64 - ₹4218.67 | -48.8% | ROE: 104.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2245.80 | ₹2021.22 - ₹2470.38 | -70.0% | EPS: ₹243.60, BVPS: ₹228.48 |
| Dividend Yield Method | dividend | ₹8500.00 | ₹7650.00 - ₹9350.00 | +13.5% | DPS: ₹255.00, Target Yield: 3.0% |
PGHH Intrinsic Value vs Market Price — All Valuation Models
P&G Hygiene and Health Care fair value range ₹1497–₹8500 vs current market price ₹7486.00 across 10 valuation models. Check P&G Hygiene and Health Care market cap to track the company's total market size over time.
PGHH Intrinsic Value Analysis — Undervalued or Overvalued?
P&G Hygiene and Health Care median intrinsic value ₹3835.15, current price ₹7486.00 — Trading Above Calculated Value by 48.8%, margin of safety -95.2%.
What is the intrinsic value of PGHH?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of P&G Hygiene and Health Care (PGHH) is ₹3835.15 (median value). With the current market price of ₹7486.00, this represents a -48.8% variance from our estimated fair value.
The valuation range spans from ₹1497.20 to ₹8500.00, indicating ₹1497.20 - ₹8500.00.
Is PGHH undervalued or overvalued?
Based on our multi-method analysis, P&G Hygiene and Health Care (PGHH) appears to be trading above calculated value by approximately 48.8%.
PGHH Financial Health — Key Ratios vs Industry Benchmarks
P&G Hygiene and Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.95 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 104.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 25.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.38x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
PGHH Cash Flow Quality — Operating & Free Cash Flow
P&G Hygiene and Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹924 Cr | ₹924 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹598 Cr | ₹581 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹470 Cr | ₹470 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹826 Cr | ₹821 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹573 Cr | ₹560 Cr | Positive Free Cash Flow | 8/10 |